Images

Filter by

Table 3 Hypertrophic Cardiomyopathy
Table 3. Hypertrophic Cardiomyopathy
Table 2 Brugada Syndrome
Table 2. Brugada Syndrome
Table 1 Arrhythmogenic Right Ventricular Dysplasia
Table 1. Arrhythmogenic Right Ventricular Dysplasia
Figure 1 A Synopsis of the Thyroid Hormone mediated Cardioprotection
Figure 1: A Synopsis of the Thyroid Hormone-mediated Cardioprotection
Table 1 Experimental Conditions in which Thyroid Hormone Exert a Cardioprotective Effect
Table 1: Experimental Conditions in which Thyroid Hormone Exert a Cardioprotective Effect
Figure 3 Data from a Meta analysis Comparing Clinical
Figure 3: Data from a Meta-analysis Comparing Clinical
Table 3 A Summary of Meta analysis of Clinical Studies Investigating Trimetazidine in Heart Failure
Table 3: A Summary of Meta-analysis of Clinical Studies Investigating Trimetazidine in Heart Failure
Figure 2 Effect of Trimetazidine and Conventional Therapy Alone on Quality of Life
Figure 2: Effect of Trimetazidine and Conventional Therapy Alone on Quality of Life
Table 2 Summary of Clinical Studies Investigating Trimetazidine in Heart Failure
Table 2: Summary of Clinical Studies Investigating Trimetazidine in Heart Failure
Figure 1 Patients From the SHIFT Trial Reaching the Composite Primary Endpoint in Placebo and Ivabradine Groups
Figure 1: Patients From the SHIFT Trial Reaching the Composite Primary Endpoint in Placebo and Ivabradine Groups
Table 1 Clinical Studies Investigating Ivabradine in Heart Failure
Table 1: Clinical Studies Investigating Ivabradine in Heart Failure
Table 2 European Society of Cardiology Practical Guidance on the Use of Ivabradine in Patients with Heart Failure with lt br gt 10 Reduced Ejection Fraction
Table 2: European Society of Cardiology Practical Guidance on the Use of Ivabradine in Patients with Heart Failure with<br />
Reduced Ejection Fraction